marginally non-significantP = 0.057
At the 2-year follow-up, the association was marginally non-significant (Exp(β) = 1.17, 95% CI: 1.00–1.38, P = 0.057).
At the 2-year follow-up, the association was marginally non-significant (Exp(β) = 1.17, 95% CI: 1.00–1.38, P = 0.057).
At the 2-year follow-up, the association between possible sarcopenia and mortality in obese patients was borderline significant ( P = 0.0823, Figure S1 A), while possible sarcopenia was associated with increased mortality risk in all other subgroups.